whether we should stimulate immune response in allergic children with respiratory infections? results of scientific studies and their significance for clinical practice

Clicks: 233
ID: 169129
2011
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #13 of 111 articles by views in Biocontrol science

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract

This survey contains efficacy analysis and substantiation of treatment of allergic children with respiratory infections with modern immune modulators. Evolution of immunomodulates is followed up on the example of pidotimod as well as its efficacy based on its influence on immunoregulation system and mucosal immunity. The authors underline the necessity of reasonable prescription of medications with immunostimulating activity to children with various forms of respiratory infections.

Key words: children, acute respiratory infections, allergic diseases, immunomodulators, pidotimod.
(Voprosy sovremennoi pediatrii — Current Pediatrics. — 2011; 10 (6): 166–169)

Reference Key
karaulov2011voprosywhether Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;A.V. Karaulov
Journal Biocontrol science
Year 2011
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.